PUBLISHER: The Business Research Company | PRODUCT CODE: 1760497
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760497
Candesartan Cilexetil Drug Global Market Report 2025
Candesartan cilexetil is an angiotensin II receptor antagonist primarily used to treat high blood pressure and heart failure. It works by blocking the effects of angiotensin II, helping to relax blood vessels and lower blood pressure.
The main product types of candesartan cilexetil include tablets, capsules, and other forms. Tablets are solid dosage forms that typically consist of a mixture of active pharmaceutical ingredients and excipients, compressed into a small, convenient shape. Candesartan cilexetil is used for multiple indications, including hypertension, heart failure, diabetic nephropathy, and left ventricular hypertrophy. The available dosage strengths are 4 mg, 8 mg, 16 mg, and 32 mg. The drug is distributed through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and healthcare facilities. It is used for a range of applications in adults, children, and adolescents.
The candesartan cilexetil drug market research report is one of a series of new reports from The Business Research Company that provides candesartan cilexetil drug market statistics, including the candesartan cilexetil drug industry global market size, regional shares, competitors with the candesartan cilexetil drug market share, detailed candesartan cilexetil drug market segments, market trends, and opportunities, and any further data you may need to thrive in the candesartan cilexetil drug industry. This candesartan cilexetil drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The candesartan cilexetil drug market size has grown strongly in recent years. It will grow from $1.57 billion in 2024 to $1.67 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth during the historic period can be attributed to the rising prevalence of hypertension, the increasing geriatric population, a higher incidence of chronic diseases, a greater focus on preventative care, and the growing healthcare expenditure.
The candesartan cilexetil drug market size is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth during the forecast period can be attributed to the expansion of generic drug availability, the rising incidence of lifestyle-related diseases, government initiatives for affordable hypertension care, the increasing prevalence of cardiovascular diseases, and the growing adoption of combination therapies. Key trends in the forecast period include a shift toward generic candesartan formulations, the development of fixed-dose combination drugs, integration of digital health for hypertension monitoring, a growing focus on patient compliance, and increasing research on novel delivery mechanisms.
The rising prevalence of hypertension is expected to drive the growth of the candesartan cilexetil drug market in the future. Hypertension, commonly known as high blood pressure, is a condition in which the force of blood against the artery walls is consistently too high, typically defined by a reading of 130/80 mmHg or higher. The increasing prevalence of hypertension is largely attributed to unhealthy lifestyle choices, including poor diet, insufficient physical activity, and high-stress levels. Candesartan cilexetil helps manage hypertension by blocking the action of angiotensin II, a hormone that narrows blood vessels, thereby relaxing the vessels and lowering blood pressure. For instance, in October 2024, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported a significant increase in hypertension prevalence, rising by 124.48% from the 18-39 age group to the 40-59 age group, and by 36.38% from the 40-59 age group to individuals aged 60 and above, between August 2021 and August 2023. Therefore, the rising burden of hypertension is boosting the demand for candesartan cilexetil.
The rising incidence of cardiovascular disorders is expected to fuel the growth of the candesartan cilexetil drug market moving forward. Cardiovascular disorders are health issues that affect the heart or blood vessels, impairing heart function. The increase in cardiovascular disorders is mainly due to a lack of physical activity, which can lead to obesity, high blood pressure, and poor cardiovascular health, ultimately reducing the heart and circulatory system's efficiency. Candesartan cilexetil helps manage cardiovascular conditions by lowering blood pressure, easing the strain on the heart, and reducing the risk of complications such as heart failure, stroke, and kidney damage. For example, in January 2025, the British Heart Foundation, a UK-based cardiovascular research organization, reported that about 7.6 million people in the UK suffer from heart and circulatory diseases, including around 4 million men and 3.6 million women. These diseases contribute to nearly 27% of all deaths in the country, leading to over 170,000 fatalities annually, or about 480 deaths per day. As a result, the increasing prevalence of cardiovascular disorders is driving the growth of the candesartan cilexetil drug market.
Key players in the candesartan cilexetil drug market are focusing on developing innovative formulations, such as combination therapies with other antihypertensive medications and extended-release versions, to enhance patient adherence and improve treatment outcomes. Hypertension treatment includes medications, lifestyle changes, and other interventions aimed at lowering blood pressure to reduce the risk of complications such as heart disease, stroke, and kidney damage. For instance, in March 2025, Scienture Inc., a US-based pharmaceutical company, received approval from the US Food and Drug Administration (FDA) for its New Drug Application (NDA) for SCN-102, branded as Arbli, a losartan potassium oral suspension (10 mg/mL). This angiotensin II receptor blocker (ARB) formulation offers an alternative for patients who have difficulty swallowing tablets, particularly among pediatric and geriatric populations. The launch of this product highlights the growing interest in alternative dosage forms in the antihypertensive market and signals a shift toward more personalized, patient-friendly drug delivery systems.
Major players in the candesartan cilexetil drug market are Merck & Co. Inc., Bayer AG, Novartis AG, AstraZeneca plc, GSK plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Sandoz Group AG, Viatris Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Zydus Lifesciences Ltd., Hetero Drugs Limited, Torrent Pharmaceuticals Limited, Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Limited, Oubari Pharmaceutical Co.
North America was the largest region in the candesartan cilexetil drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in candesartan cilexetil drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the candesartan cilexetil drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The candesartan cilexetil drug market consists of sales of atacand, candesartan tablets, and oral tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Candesartan Cilexetil Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on candesartan cilexetil drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for candesartan cilexetil drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The candesartan cilexetil drug market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product Type: Tablets; Capsules; Other Product Types
- 2) By Indication: Hypertension; Heart Failure; Diabetic Nephropathy; Left Ventricular Hypertrophy
- 3) By Dosage Strength: 4 MG; 8 MG; 16 MG; 32 MG
- 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Healthcare Facilities
- 5) By Application: Adult; Children And Adolescent
- Subsegments:
- 1) By Tablets: Immediate-Release Tablets; Extended-Release Tablets; Dispersible Tablets; Chewable Tablets
- 2) By Capsules: Hard Gelatin Capsules; Soft Gelatin Capsules; Modified-Release Capsules
- 3) By Other Product Types: Oral Suspensions; Injectable Formulations; Combination Drug Formulations
- Companies Mentioned: Merck & Co. Inc.; Bayer AG; Novartis AG; AstraZeneca plc; GSK plc
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Candesartan Cilexetil Drug Market Characteristics
3. Candesartan Cilexetil Drug Market Trends And Strategies
4. Candesartan Cilexetil Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Candesartan Cilexetil Drug Growth Analysis And Strategic Analysis Framework
- 5.1. Global Candesartan Cilexetil Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Candesartan Cilexetil Drug Market Growth Rate Analysis
- 5.4. Global Candesartan Cilexetil Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Candesartan Cilexetil Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Candesartan Cilexetil Drug Total Addressable Market (TAM)
6. Candesartan Cilexetil Drug Market Segmentation
- 6.1. Global Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tablets
- Capsules
- Other Product Types
- 6.2. Global Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hypertension
- Heart Failure
- Diabetic Nephropathy
- Left Ventricular Hypertrophy
- 6.3. Global Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 4 MG
- 8 MG
- 16 MG
- 32 MG
- 6.4. Global Candesartan Cilexetil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Healthcare Facilities
- 6.5. Global Candesartan Cilexetil Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Adult
- Children And Adolescent
- 6.6. Global Candesartan Cilexetil Drug Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Immediate-Release Tablets
- Extended-Release Tablets
- Dispersible Tablets
- Chewable Tablets
- 6.7. Global Candesartan Cilexetil Drug Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hard Gelatin Capsules
- Soft Gelatin Capsules
- Modified-Release Capsules
- 6.8. Global Candesartan Cilexetil Drug Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral Suspensions
- Injectable Formulations
- Combination Drug Formulations
7. Candesartan Cilexetil Drug Market Regional And Country Analysis
- 7.1. Global Candesartan Cilexetil Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Candesartan Cilexetil Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Candesartan Cilexetil Drug Market
- 8.1. Asia-Pacific Candesartan Cilexetil Drug Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Candesartan Cilexetil Drug Market
- 9.1. China Candesartan Cilexetil Drug Market Overview
- 9.2. China Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Candesartan Cilexetil Drug Market
- 10.1. India Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Candesartan Cilexetil Drug Market
- 11.1. Japan Candesartan Cilexetil Drug Market Overview
- 11.2. Japan Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Candesartan Cilexetil Drug Market
- 12.1. Australia Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Candesartan Cilexetil Drug Market
- 13.1. Indonesia Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Candesartan Cilexetil Drug Market
- 14.1. South Korea Candesartan Cilexetil Drug Market Overview
- 14.2. South Korea Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Candesartan Cilexetil Drug Market
- 15.1. Western Europe Candesartan Cilexetil Drug Market Overview
- 15.2. Western Europe Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Candesartan Cilexetil Drug Market
- 16.1. UK Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Candesartan Cilexetil Drug Market
- 17.1. Germany Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Candesartan Cilexetil Drug Market
- 18.1. France Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Candesartan Cilexetil Drug Market
- 19.1. Italy Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Candesartan Cilexetil Drug Market
- 20.1. Spain Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Candesartan Cilexetil Drug Market
- 21.1. Eastern Europe Candesartan Cilexetil Drug Market Overview
- 21.2. Eastern Europe Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Candesartan Cilexetil Drug Market
- 22.1. Russia Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Candesartan Cilexetil Drug Market
- 23.1. North America Candesartan Cilexetil Drug Market Overview
- 23.2. North America Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Candesartan Cilexetil Drug Market
- 24.1. USA Candesartan Cilexetil Drug Market Overview
- 24.2. USA Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Candesartan Cilexetil Drug Market
- 25.1. Canada Candesartan Cilexetil Drug Market Overview
- 25.2. Canada Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Candesartan Cilexetil Drug Market
- 26.1. South America Candesartan Cilexetil Drug Market Overview
- 26.2. South America Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Candesartan Cilexetil Drug Market
- 27.1. Brazil Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Candesartan Cilexetil Drug Market
- 28.1. Middle East Candesartan Cilexetil Drug Market Overview
- 28.2. Middle East Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Candesartan Cilexetil Drug Market
- 29.1. Africa Candesartan Cilexetil Drug Market Overview
- 29.2. Africa Candesartan Cilexetil Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Candesartan Cilexetil Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Candesartan Cilexetil Drug Market, Segmentation By Dosage Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Candesartan Cilexetil Drug Market Competitive Landscape And Company Profiles
- 30.1. Candesartan Cilexetil Drug Market Competitive Landscape
- 30.2. Candesartan Cilexetil Drug Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GSK plc Overview, Products and Services, Strategy and Financial Analysis
31. Candesartan Cilexetil Drug Market Other Major And Innovative Companies
- 31.1. Takeda Pharmaceutical Company Limited
- 31.2. Teva Pharmaceutical Industries Ltd.
- 31.3. Boehringer Ingelheim International GmbH
- 31.4. Sandoz Group AG
- 31.5. Viatris Inc.
- 31.6. Sun Pharmaceutical Industries Limited
- 31.7. Aurobindo Pharma Limited
- 31.8. Dr. Reddy's Laboratories Limited
- 31.9. Cipla Limited
- 31.10. Zydus Lifesciences Ltd.
- 31.11. Hetero Drugs Limited
- 31.12. Torrent Pharmaceuticals Limited
- 31.13. Macleods Pharmaceuticals Ltd.
- 31.14. Alembic Pharmaceuticals Limited
- 31.15. Oubari Pharmaceutical Co.
32. Global Candesartan Cilexetil Drug Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Candesartan Cilexetil Drug Market
34. Recent Developments In The Candesartan Cilexetil Drug Market
35. Candesartan Cilexetil Drug Market High Potential Countries, Segments and Strategies
- 35.1 Candesartan Cilexetil Drug Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Candesartan Cilexetil Drug Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Candesartan Cilexetil Drug Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
